Insider Transactions in Q2 2021 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2021
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
2,084
-70.05%
|
$1,144,116
$549.0 P/Share
|
|
Jun 25
2021
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,084
+41.19%
|
$773,164
$371.4 P/Share
|
|
Jun 24
2021
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Bona fide gift
|
Indirect |
211,585
-100.0%
|
-
|
|
Jun 24
2021
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Bona fide gift
|
Indirect |
211,585
+49.75%
|
-
|
|
Jun 21
2021
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Open market or private sale
|
Indirect |
80,000
-21.7%
|
$43,040,000
$538.04 P/Share
|
|
Jun 14
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
19,000
-5.81%
|
-
|
|
Jun 14
2021
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,700
-65.61%
|
$892,500
$525.0 P/Share
|
|
Jun 14
2021
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,700
+39.62%
|
$630,700
$371.4 P/Share
|
|
Jun 14
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$52,500
$525.51 P/Share
|
|
Jun 07
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$511,000
$511.65 P/Share
|
|
Jun 07
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Jun 07
2021
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
1,930
-24.68%
|
$1,013,250
$525.0 P/Share
|
|
Jun 07
2021
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,930
+19.79%
|
$721,820
$374.12 P/Share
|
|
May 27
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
22,000
-6.3%
|
-
|
|
May 19
2021
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Bona fide gift
|
Indirect |
41,178
-100.0%
|
-
|
|
May 19
2021
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
BUY
Bona fide gift
|
Indirect |
41,178
+50.0%
|
-
|
|
May 17
2021
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
17,521
-16.18%
|
$9,093,399
$519.42 P/Share
|
|
May 14
2021
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
34,979
-28.95%
|
$18,049,164
$516.69 P/Share
|
|
May 14
2021
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
52,500
+29.34%
|
$6,037,500
$115.58 P/Share
|
|
May 07
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$495,000
$495.63 P/Share
|
|
May 07
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Apr 01
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
446
-0.31%
|
-
|